TY - JOUR
T1 - Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain
AU - Nazari, Qand Agha
AU - Takada-Takatori, Yuki
AU - Hashimoto, Tadashi
AU - Imaizumi, Atsushi
AU - Izumi, Yasuhiko
AU - Akaike, Akinori
AU - Kume, Toshiaki
PY - 2014/5
Y1 - 2014/5
N2 - Curcumin, a polyphenolic compound has several pharmacological activities, such as anticancer, anti-inflammatory and antioxidant effects. However, curcumin shows poor oral bioavailability. The purpose of this study was to investigate the protective effects of highly bioavailable curcumin, Theracurmin ®, and curcumin, against sodium nitroprusside (SNP)-induced oxidative damage in mice brain. Intrastriatal microinjection of Theracurmin ® or curcumin with SNP significantly protected against SNP-induced brain damage and motor dysfunction. Oral administration of Theracurmin® (1 and 3 g kg-1, containing 100 and 300 mg kg-1 curcumin, respectively) significantly protected against SNP-induced brain damage and motor dysfunction. However, oral administration of 300 mg kg-1 curcumin did not protect against motor dysfunction induced by SNP. These results suggest that curcumin and Theracurmin ® have protective effects against SNP-induced oxidative damage. Moreover, oral administration of Theracurmin®, had more potency in protecting against brain damage, suggesting a higher bioavailability of Theracurmin® following oral administration.
AB - Curcumin, a polyphenolic compound has several pharmacological activities, such as anticancer, anti-inflammatory and antioxidant effects. However, curcumin shows poor oral bioavailability. The purpose of this study was to investigate the protective effects of highly bioavailable curcumin, Theracurmin ®, and curcumin, against sodium nitroprusside (SNP)-induced oxidative damage in mice brain. Intrastriatal microinjection of Theracurmin ® or curcumin with SNP significantly protected against SNP-induced brain damage and motor dysfunction. Oral administration of Theracurmin® (1 and 3 g kg-1, containing 100 and 300 mg kg-1 curcumin, respectively) significantly protected against SNP-induced brain damage and motor dysfunction. However, oral administration of 300 mg kg-1 curcumin did not protect against motor dysfunction induced by SNP. These results suggest that curcumin and Theracurmin ® have protective effects against SNP-induced oxidative damage. Moreover, oral administration of Theracurmin®, had more potency in protecting against brain damage, suggesting a higher bioavailability of Theracurmin® following oral administration.
UR - http://www.scopus.com/inward/record.url?scp=84899505008&partnerID=8YFLogxK
U2 - 10.1039/c4fo00009a
DO - 10.1039/c4fo00009a
M3 - 学術論文
C2 - 24637610
AN - SCOPUS:84899505008
SN - 2042-6496
VL - 5
SP - 984
EP - 989
JO - Food and Function
JF - Food and Function
IS - 5
ER -